Esculentin 1-21: A linear antimicrobial peptide from frog skin with inhibitory effect on bovine mastitis-causing bacteria

Journal of Peptide Science

Volumn 15, Issue 9, 2009, Pages 607-614

  Islas Rodrìguez, Alfonso Enrique ^a   Marcellini, Ludovica ^b   Orioni, Barbara ^c   Barra, Donatella ^b   Stella, Lorenzo ^c   Mangoni, Maria Luisa ^b  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Anti infective agent; Antimicrobial peptide; Esculentin; Frog skin; Mastitis; Mode of action; Multidrug resistant strains; Peptide membrane interaction

Indexed keywords

AMPICILLIN; CEPHALOSPORIN C; ESCULENTIN [1-21]; POLYPEPTIDE ANTIBIOTIC AGENT; TETRACYCLINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; CELL MEMBRANE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY TEST; DAIRY CATTLE; DRUG DESIGN; DRUG POTENCY; DRUG SYNTHESIS; EVENING DOSAGE; FROG; KLEBSIELLA PNEUMONIAE; MASTITIS; MEMBRANE TRANSPORT; MORNING DOSAGE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS DYSGALACTIAE; TREATMENT DURATION; TREATMENT RESPONSE;

AMPHIBIAN PROTEINS; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; ANURA; CATTLE; CELL LINE; CELL MEMBRANE; CELL SURVIVAL; CIRCULAR DICHROISM; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HEMOLYSIS; HUMANS; MASTITIS, BOVINE;

ANIMALIA; ANURA; BACTERIA (MICROORGANISMS); BOS; BOVINAE; STREPTOCOCCUS AGALACTIAE;

EID: 70349647481     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1148     Document Type: Conference Paper

References (48)

1. Cao LT, Wu JQ, Xie F, Hu SH, Mo Y. Efficacy of nisin in treatment of clinical mastitis in lactating dairy cows. J. Dairy Sci. 2007; 90: 3980-3985.
2. Blosser TH. Economic losses fromand the national research program on mastitis in the United States. J. Dairy Sci. 1979; 62: 119-127.
3. Kitchen BJ. Review of the progress of dairy science: bovine mastitis: milk compositional changes and related diagnostic tests. J. Dairy Res. 1981; 48: 167-188.
4. Urech E, Puhan Z, Schallibaum M. Changes in milk protein fraction as affected by subclinical mastitis. J. Dairy Sci. 1999; 82: 2402-2411.
5. Wu J, Hu S, Cao L. Therapeutic effect of nisin Z on subclinical mastitis in lactating cows. Antimicrob. Agents Chemother. 2007; 51: 3131-3135.
6. Hancock REW, Patrzykat A. Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics. Curr. Drug Targets Infect. Disord. 2002; 2: 79-83.
7. Hancock REW, Sahl HG. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 2006; 24: 1551-1557.
8. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002; 415: 389-395.
9. Boman HG. Peptide antibiotics and their role in innate immunity. Annu. Rev. Immunol. 1995; 13: 61-92.
10. Gough M, Hancock RE, Kelly NM. Antiendotoxin activity of cationic peptide antimicrobial agents. Infect. Immun. 1996; 64: 4922-4927.
11. Bowdish DM, Davidson DJ, Hancock RE. A re-evaluation of the role of host defence peptides inmammalian immunity. Curr. Protein Pept. Sci. 2005; 6: 35-51.
12. Periti P, Mazzei T. New criteria for selecting the proper antimicrobial chemotherapy for severe sepsis and septic shock. Int. J. Antimicrob. Agents 1999; 12: 97-105.
13. Yang D, Biragyn A, Kwak LW, Oppenheim JJ. Mammalian defensins in immunity:more than just microbicidal. Trends Immunol. 2002; 23: 291-296.
14. Bals R, Wilson JM. Cathelicidins-a family of multifunctional antimicrobial peptides. Cell. Mol. Life Sci. 2003; 60: 711-720.
15. Bowdish DM, Davidson DJ, Lau YE, Lee K, Scott MG, Hancock RE. Impact of LL-37 on anti-infective immunity. J. Leukoc. Biol. 2005; 77: 451-459.
16. Hancock RE, Rozek A. Role of membranes in the activities of antimicrobial cationic peptides. FEMS Microbiol. Lett. 2002; 206: 143-149.
17. Shai Y. Mechanism of the binding, insertion and destabilization of phospholipid bilayermembranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta 1999; 1462: 55-70.
18. Shai Y. Mode of action of membrane active antimicrobial peptides. Biopolymers 2002; 66: 236-248.
19. Shai Y. From innate immunity to de-novo designed antimicrobial peptides. Curr. Pharm. Des. 2002; 8: 715-725.
20. Simmaco M, Mignogna G, Barra D. Antimicrobial peptides from amphibianskin:what do they tell us?. Biopolymers 1998; 47:435-450.
21. Mangoni ML, Miele R, Renda TG, Barra D, Simmaco M. The synthesis of antimicrobial peptides in the skin of Rana esculenta is stimulated by microorganisms. FASEB J. 2001; 15: 1431-1432.
22. Simmaco M, Mignogna G, Barra D, Bossa F. Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides. J. Biol. Chem. 1994; 269: 11956-11961.
23. Ponti D, Mignogna G, Mangoni ML, De Biase D, Simmaco M, Barra D. Expression and activity of cyclic and linear analogues of esculentin-1, an anti-microbial peptide from amphibian skin. Eur. J. Biochem. 1999; 263: 921-927.
24. Mangoni ML. Temporins, anti-infective peptides with expanding properties. Cell. Mol. Life Sci. 2006; 63: 1060-1069.
25. Mangoni ML, Papo N, Saugar JM, Barra D, Shai Y, Simmaco M, Rivas L. Effect of natural L- to D-amino acid conversion on the organization, membrane binding, and biological function of the antimicrobial peptides bombinins H. Biochemistry 2006; 45: 4266-4276.
26. Mangoni ML, Papo N, Mignogna G, Andreu D, Shai Y, Barra D, Simmaco M. Ranacyclins, a new family of short cyclic antimicrobial peptides: biological function, mode of action, and parameters involved in target specificity. Biochemistry 2003; 42: 14023-14035.
27. Conlon JM. Reflections on a systematic nomenclature for antimicrobial peptides from the skins of frogs of the family Ranidae. Peptides 2008; 29: 1815-1819.
28. Mangoni ML, Fiocco D,Mignogna G, Barra D,Simmaco M. Functional characterisation of the 1-18 fragment of esculentin-1b, an antimicrobial peptide from Rana esculenta. Peptides 2003; 24: 1771-1777.
29. Gamberi T, Cavalieri D, Magherini F, Mangoni ML, De Filippo C, Borro M, Gentile G, Simmaco M, Modesti A. An integrated analysis of the effects of Esculentin 1-21 on Saccharomyces cerevisiae. Biochim. Biophys. Acta 2007; 1774: 688-700.
30. Krukowski H, Lisowski A, Rozanski P, Skorka A. Yeasts and algae isolated from cows with mastitis in the south-eastern part of Poland. Pol. J. Vet. Sci. 2006; 9: 181-184.
31. Chahota R, Katoch R, Mahajan A. Clinical bovine mastitis caused by Geotrichum candidum. Vet. Arhiv. 2001; 71: 197-201.
32. Nicolas P, El Amri C. The dermaseptin superfamily: A gene-based combinatorial library of antimicrobial peptides. Biochim. Biophys. Acta 2008 (in press).
33. Mangoni ML, Grovale N, Giorgi A, Mignogna G, Simmaco M, Barra D. Structure-function relationships in bombinins H, antimicrobial peptides from Bombina skin secretions. Peptides 2000; 21: 1673-1679.
34. Hultmark D, Engstrom A, Andersson K, Steiner H, Bennich H, Boman HG. Insect immunity. Attacins, a family of antibacterial proteins from Hyalophora cecropia. EMBO J. 1983; 2: 571-576.
35. Ruegg PL. California Mastitis Test (CMT). http://www.uwex.edu/ milkquality/PDF/Vol3pdf/Pg31618CMTfactsheet1.pdf. 2005.
36. Fortin M, Messier S, Pare J, Higgins R. Identification of catalase-negative, non-beta-hemolytic, gram-positive cocci isolated from milk samples. J. Clin. Microbiol. 2003; 41: 106-109.
37. National CM. Laboratory and Field Handbook on Bovine Mastitis. National Mastitis Council: 1999; 11-19.
38. Broadbent JR, Chou YC, Gillies K, Kondo JK. Nisin inhibits several gram-positive, mastitis-causing pathogens. J. Dairy Sci. 1989; 72: 3342-3345.
39. Munoz MA, Welcome FL, Schukken YH, Zadoks RN. Molecular epidemiology of two Klebsiella pneumoniae mastitis outbreaks on a dairy farm in New York State. J. Clin. Microbiol. 2007; 45: 3964-3971.
40. Philpot WN. Control of mastitis by hygiene and therapy. J. Dairy Sci. 1979; 62: 168-176.
41. Keefe GP. Streptococcus agalactiae mastitis: a review. Can. Vet. J. 1997; 38: 429-437.
42. Maisetta G, Batoni G, Esin S, Florio W, Bottai D, Favilli F, Campa M. In vitro bactericidal activity of human beta-defensin 3 against multidrug-resistant nosocomial strains. Antimicrob. Agents Chemother. 2006; 50: 806-809.
43. Oren Z, Hong J, Shai Y. A repertoire of novel antibacterial diastereomeric peptides with selective cytolytic activity. J. Biol. Chem. 1997; 272: 14643-14649.
44. Zhao X, Lacasse P. Mammary tissue damage during bovine mastitis: causes and control. J. Anim. Sci. 2008; 86: 57-65.
45. Sordillo LM, Nickerson SC, Akers RM, Oliver SP. Secretion composition during bovine mammary involution and the relationship with mastitis. Int. J. Biochem. 1987; 19: 1165-1172.
46. Read AF, Graham AL, Raberg L. Animal defenses against infectious agents: is damage control more important than pathogen control. PLoS Biol. 2008; 6: 2638-2641.
47. Gilmore TM, Ellefson RA, Parsons JG. Dye marked antibiotics in dry cowmastitis therapy. J. Dairy Sci. 1986; 69: 1128-1134.
48. Morse D, DeLorenzo MA, Natzke RP, Bray DR. Factors affecting days of discarded milk due to clinical mastitis and subsequent cost of discarded milk. J. Dairy Sci. 1987; 70: 2411-2418.